PET studies of D2-receptor binding in striatal and extrastriatal brain regions: Biochemical support in vivo for separate dopaminergic systems in humans

Synapse ◽  
2010 ◽  
Vol 64 (6) ◽  
pp. 478-485 ◽  
Author(s):  
Simon Cervenka ◽  
Andrea Varrone ◽  
Erik Fransén ◽  
Christer Halldin ◽  
Lars Farde
2002 ◽  
Vol 17 (3) ◽  
pp. 557-562 ◽  
Author(s):  
Guy Arnold ◽  
Klaus Tatsch ◽  
Eduardo Kraft ◽  
Wolfgang H. Oertel ◽  
Johannes Schwarz

1999 ◽  
Vol 19 (2) ◽  
pp. 218-229 ◽  
Author(s):  
Evan D. Morris ◽  
Svetlana I. Chefer ◽  
Mark A. Lane ◽  
Raymond F. Muzic ◽  
Dean F. Wong ◽  
...  

The relation between striatal dopamine D2 receptor binding and aging was investigated in rhesus monkeys with PET. Monkeys (n = 18, 39 to 360 months of age) were scanned with 11C-raclopride; binding potential in the striatum was estimated graphically. Because our magnetic resonance imaging analysis revealed a concomitant relation between size of striatum and age, the dynamic positron emission tomography (PET) data were corrected for possible partial volume (PV) artifacts before parameter estimation. The age-related decline in binding potential was 1% per year and was smaller than the apparent effect if the age-related change in size was ignored. This is the first in vivo demonstration of a decline in dopamine receptor binding in nonhuman primates. The rate of decline in binding potential is consistent with in vitro findings in monkeys but smaller than what has been measured previously in humans using PET. Previous PET studies in humans, however, have not corrected for PV error, although a decline in striatal size with age has been demonstrated. The results of this study suggest that PV correction must be applied to PET data to accurately detect small changes in receptor binding that may occur in parallel with structural changes in the brain.


2020 ◽  
Vol 1748 ◽  
pp. 147074 ◽  
Author(s):  
Edina Szűcs ◽  
Eszter Ducza ◽  
Alexandra Büki ◽  
Gabriella Kekesi ◽  
Sándor Benyhe ◽  
...  

1990 ◽  
Vol 259 (4) ◽  
pp. H1278-H1287 ◽  
Author(s):  
R. Kawai ◽  
Y. Sawada ◽  
M. Channing ◽  
A. H. Newman ◽  
K. C. Rice ◽  
...  

The "rapid-phase" brain distribution of 3H-labeled enantiomers of the opiate receptor antagonist cyclofoxy (CF), receptor active (-) and inert (+) forms, was measured during 20- to 180-s intravenous infusion in rats. [14C]iodoantipyrine was coinfused during these experiments to obtain a simultaneous measure of blood flow. The influx clearance (K1) across the blood-brain barrier (BBB) and the rapid binding equilibrium constant (Keq) were estimated in different brain regions for both enantiomers (2-compartmental model); a possible receptor binding process (k3) was also examined for (-)-CF (3-compartment model). K1 (0.46-0.91 ml.min-1.g-1), the capillary permeability-surface area product (PS; 0.75 approximately 1.4 ml.min-1.g-1) and the tissue extraction fraction (E; 0.6-0.7) were found to be identical for both enantiomers in the nonreceptor binding model; Keq was identical in cerebellum but larger for (-)-CF in other brain structures. The difference in Keq between the enantiomers (2-compartment model) correlated with the rank order of opiate receptor density observed in vitro and in vivo. These results suggest that concomitant use of (-)-CF and (+)-CF will be useful for in vivo receptor binding analyses.


1999 ◽  
Vol 19 (5) ◽  
pp. 533-546 ◽  
Author(s):  
Jacques Delforge ◽  
Michel Bottlaender ◽  
Christian Loc'h ◽  
Ilonka Guenther ◽  
Chantal Fuseau ◽  
...  

The multi-injection approach has been used to study in baboon the in vivo interactions between the D2 receptor sites and FLB 457, a ligand with a very high affinity for these receptors. The model structure was composed of four compartments (plasma, free ligand, and specifically and unspecifically bound ligands) and seven parameters (including the D2 receptor site density). The arterial plasma concentration, after correction for metabolites, was used as the input function, The experimental protocol, which consisted of three injections of labeled and/or unlabeled ligand, allowed the evaluation of all model parameters from a single positron emission tomography experiment In particular, the concentration of receptor sites available for binding ( B'max) and the apparent in vivo FLB 457 affinity were estimated in seven brain regions, including the cerebellum and several cortex regions, in which these parameters are estimated in vivo for the first time ( B'max is estimated to be 4,0 ± 1.3 pmol/mL in the thalamus and from 0.32 to 1.90 pmol/mL in the cortex), A low receptor density was found in the cerebellum ( B'max = 0.39 ± 0.17 pmol/mL), whereas the cerebellum is usually used as a reference region assumed to be devoid of D2 receptor sites, In spite of this very small concentration (1 % of the striatal concentration), and because of the high affinity of the ligand, we demonstrated that after a tracer injection, most of the PET-measured radioactivity in the cerebellum results from the labeled ligand bound to receptor sites, The estimation of all the model parameters allowed simulations that led to a precise knowledge of the FLB 457 kinetics in all brain regions and gave the possibility of testing the equilibrium hypotheses and estimating the biases introduced by the usual simplified approaches.


2001 ◽  
Vol 28 (4) ◽  
pp. 383-389 ◽  
Author(s):  
Hongfeng Li ◽  
Franz J. Gildehaus ◽  
Stefan Dresel ◽  
Jörg T. Patt ◽  
Minghua Shen ◽  
...  

2009 ◽  
Vol 42 (05) ◽  
Author(s):  
M Klomp ◽  
L Rademacher ◽  
M Raptis ◽  
KN Spreckelmeyer ◽  
I Vernaleken ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document